TOMASSETTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 5.779
AS - Asia 4.815
EU - Europa 4.016
SA - Sud America 304
AF - Africa 261
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 15.180
Nazione #
US - Stati Uniti d'America 5.735
VN - Vietnam 1.567
CN - Cina 1.261
GB - Regno Unito 1.253
SG - Singapore 1.200
DE - Germania 542
SE - Svezia 416
IT - Italia 382
UA - Ucraina 379
FR - Francia 302
HK - Hong Kong 252
RU - Federazione Russa 237
IN - India 225
BR - Brasile 222
IE - Irlanda 134
JP - Giappone 90
ZA - Sudafrica 87
EE - Estonia 85
CH - Svizzera 81
FI - Finlandia 70
TG - Togo 60
CI - Costa d'Avorio 42
KR - Corea 42
AR - Argentina 41
NL - Olanda 40
SC - Seychelles 28
NG - Nigeria 24
BD - Bangladesh 23
BE - Belgio 22
TH - Thailandia 19
CA - Canada 18
JO - Giordania 17
EC - Ecuador 16
MX - Messico 16
PH - Filippine 15
PL - Polonia 15
TW - Taiwan 15
UZ - Uzbekistan 15
AT - Austria 14
TR - Turchia 13
BG - Bulgaria 10
GR - Grecia 10
IQ - Iraq 10
PK - Pakistan 8
ID - Indonesia 7
CL - Cile 6
IR - Iran 6
LB - Libano 6
PY - Paraguay 6
SA - Arabia Saudita 6
EG - Egitto 5
MA - Marocco 5
MY - Malesia 5
RO - Romania 5
CO - Colombia 4
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
CZ - Repubblica Ceca 3
ES - Italia 3
HU - Ungheria 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
ET - Etiopia 2
HR - Croazia 2
NP - Nepal 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.180
Città #
Southend 1.126
Singapore 788
Fairfield 618
Ashburn 515
Chandler 388
Ho Chi Minh City 316
Seattle 294
Woodbridge 290
San Jose 280
Wilmington 280
Hanoi 273
Jacksonville 266
Dong Ket 258
Houston 253
Hong Kong 247
Santa Clara 244
Cambridge 229
Princeton 224
Ann Arbor 180
Beijing 150
Hefei 141
Boardman 135
Dublin 133
Lauterbourg 120
Padova 105
Westminster 103
Nanjing 102
Tokyo 82
Berlin 79
Los Angeles 76
Bern 74
Helsinki 70
Lomé 60
Milan 58
Da Nang 53
Shenyang 53
Nanchang 50
Saint Petersburg 49
Mülheim 47
Bologna 46
Jinan 46
Abidjan 42
Haiphong 39
San Diego 38
New York 37
Medford 35
Seoul 35
Changsha 34
Tianjin 34
Buffalo 33
Dallas 30
Guangzhou 30
Shanghai 28
Hebei 27
São Paulo 27
Redondo Beach 26
Des Moines 25
Abeokuta 24
Mahé 24
Frankfurt am Main 22
Biên Hòa 18
Fuzhou 18
Jiaxing 18
Wuhan 18
Amman 17
Ningbo 17
Brussels 16
Turin 16
Bremen 15
Hải Dương 15
Norwalk 15
Washington 15
Yubileyny 15
Bengaluru 14
Hangzhou 14
Zhengzhou 14
Verona 13
Ha Long 12
Haikou 12
Phoenix 12
Shijiazhuang 12
Dearborn 11
Paris 11
Can Tho 10
Falkenstein 10
Olalla 10
Quận Bình Thạnh 10
Sofia 10
Florence 9
London 9
Ninh Bình 9
Taizhou 9
Vienna 9
Vinh 9
Bắc Giang 8
Bắc Ninh 8
Chengdu 8
Kunming 8
Lanzhou 8
Phủ Lý 8
Totale 9.981
Nome #
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. 329
Basis for treatment of functioning neuroendocrine tumours. 227
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 224
Chromogranin A: is it a useful marker of neuroendocrine tumors? 222
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 221
Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors 218
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. 217
Endocrine pancreatic tumors: factors correlated with survival. 216
A case of primary pancreatic lymphoma. 210
WHO 2010 classification of pancreatic endocrine tumors. Is the new always better than the old? 208
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 198
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 196
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 195
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 192
The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay. 192
Exocrine pancreatic function after alcoholic or biliary acute pancreatitis 189
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. 188
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 184
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 184
Endocrine tumors of the ileum: factors correlated with survival. 184
The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours. 183
Il percorso diagnostico preoperatorio e la preparazione all'intervento chirurgico 175
Capsule endoscopy for the diagnosis of midgut neuroendocrine carcinoma. 174
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. 172
Medical treatment of endocrine gastroenteropancreatic tumors. 170
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 169
Zollinger-Ellison syndrome. Diagnosis and therapy. 168
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. 168
Clinical approach to diarrhea 168
Water-related techniques in colonoscopy: the end justifies the means! 164
Sedation during colonoscopy and the benefits of lubrication 159
Pancreatic endocrine tumors less than 4 cm in diameter: resect or enucleate? a single-center experience. 158
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours 157
Lubrication during colonoscopy: a forgotten factor. 156
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 155
Patient-reported outcomes in patients with endocrine tumors of the Ileum 154
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 151
Routine duodenal biopsies: is it time to change our minds? 150
Warm water and oil assistance in colonoscopy 150
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. 148
Ipotesi di percorso diagnostico terapeutico dei tumori del pancreas. 147
Characterization of neuroendocrine pancreatic cancer with multidetector computer tomography and magneti resonance. 147
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs 147
Long-term survival in neuroendocrine tumors of the pancreas. 146
WHO-2010 and WHO-2000 classifications for pancreatic endocrine tumors. Is it time to change ? 145
Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases 144
Patient-reported outcomes in subjects with neuroendocrine tumors of the pancreas. 144
CRITICAL ANALYSIS ON MANAGEMENT OF GIST PATIENTS WITH EVENT TREE MODEL 143
Maffucci syndrome with hemangioma of the liver 142
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 142
Warm water and oil for the difficult colon 142
Neuroendocrine tumor of the pancreas and GIST: is there a correlation? 140
Multiple gastric endocrine tumors and gastrinomas of the duodenum in a patient with a ZES MEN I 140
Oil-lubricated colonoscopy: easier and less painful? 139
Warm water or oil-assisted colonoscopy: toward simpler examinations? 139
Neuroendocrine tumor of the pancreas and GIST: is there a correlation ? 137
Sedation on demand and lubrication during colonoscopy: should we change our mind ? 137
Lymph Node Ratio as a Prognostic Factor in Patients with Pancreatic Endocrine Tumours JOP 137
Treatment of Zollinger-Ellison Syndrome 137
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational study. 136
Quality of life in chronic pancreatitis. 134
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 133
Characterization of neuroendocrine pancreatic cancer with multidetector computed tomography and magnetic resonance. 133
Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. 133
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. 130
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 130
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. 128
Echo-enhanced ultrasonography: is it the future gold standard of imaging in acute pancreatitis? 127
Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? 127
ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. 125
68Ga-DOTA-NOC and 18F-DOPA PET in the evaluation of patients with neuroendocrine tumours. 123
Management of acute pancreatitis: current knowledge and future perspectives. 121
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of (90) Y-DOTA-D-Phe1-Tyr3 octreotide. 121
Neuroendocrine Tumours with Secondary Liver Lesions 118
Factors related to long-term survival in patients affected by well-differentiated endocrine tumors of the pancreas. ISRN Surg. 389385. [IF: 2.000] 118
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. 118
Risk and Protective Factors for Small Intestine Neuroendocrine Tumours: A Prospective Case-Control Study 118
PET/CT with 68Gallium-DOTA-peptides in NET: an overview. 117
null 117
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al. 117
The search of the stool and blood K-ras mutations in patients with pancreatic mass. 116
Warm water or oil-assisted colonoscopy: toward simpler examination ? 116
Surgical treatment of non-functioning pancreatic islet cell tumors 115
Benign pancreatic hyperenzymemia: Lights on a clinical challenge 115
Neoplasie endocrine del pancreas: follow-up clinico e terapeutico. In Attualità in pancreatologia. 114
WHO 2010 and WHO 2000 Classification: From a Sensitive Analysis to Reality 113
Everolimus for advanced pancreatic neuroendocrine tumors. 113
Medical Therapy of Malabsorption in Patients with Head Pancreatic Resection 110
Contrast-enhanced ultrasound in the differential diagnosis between esocrine and endocrine solid tumors of the pancreas. 108
Are there prognostics factors related to recurrence in neuroendocrine pancreatic tumors ? 105
PATINUM-BASED CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE GASTROINTESTINAL AND UNKNOWN PRIMARY NEUROENDOCRINE NEOPLASMS 104
Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors. 103
Prognostic value of 68Ga-DOTA-NOC PET/CT SUVmax in patients with neuroendocrine tumours of the pancreas 103
Functional imaging of digestive endocrine tumors. 101
Oil-lubricated colonoscopy: a new technique for easier examination? 96
Neoplasie endocrine del pancreas: follow-up clinico e terapeutico. 95
Somatostatin analogues: The state of the art. 94
Surgical treatment of non-functioning islet cell tumors. 87
The surgical treatment of neuroendocrine pancreatoduodenal tumors in multiple endocrine neoplasia type 1 87
The search of the stool and blood K-ras mutations in patients with pancreatic mass. A prospective study. 85
Totale 14.842
Categoria #
all - tutte 40.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.893


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021649 0 0 0 0 0 0 0 0 0 71 105 473
2021/20221.885 224 67 115 159 149 100 35 114 50 74 501 297
2022/20231.874 195 285 91 224 148 129 43 75 317 58 162 147
2023/2024439 40 89 41 47 51 74 21 16 17 18 7 18
2024/20251.782 38 351 165 111 433 87 130 40 6 84 11 326
2025/20263.895 424 439 410 291 497 230 369 215 778 242 0 0
Totale 15.345